8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)
Published . Updated .
8-K - VERTEX PHARMACEUTICALS / MA filed an 8-K with the SEC on Oct 20 (a notice of a material company event).
Directly affected
Indirectly affected
- SPY SPDR S&P 500+1.6%
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond-1.8%
Long-term U.S. government bonds
- QQQ Invesco QQQ+2.3%
Large technology stocks
- GLD SPDR Gold Shares-3.3%
Gold can move with the broad market
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VRTX | -2.80% | -2.86% | base | +1.97% | +4.03% | after close | after close |
| VERX | -10.96% | -6.63% | base | +2.44% | +6.74% | after close | after close |
| SPY | +0.07% | -0.75% | base | +0.53% | -0.66% | after close | after close |
| TLT | -1.55% | -0.11% | base | +0.15% | +2.01% | after close | after close |
| QQQ | +1.64% | -1.03% | base | +1.12% | -1.76% | after close | after close |
| GLD | -0.45% | +1.15% | base | +0.34% | -2.28% | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-20 AccNo: 0000875320-26-000278 Size: 138 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Source: sec-edgar
Price since this story was published: Vertex Pharmaceuticals Inc / Ma (VRTX)
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +0.34% | final price |
| GLD | the next day | -2.28% | final price |
| GLD | three days earlier | +1.15% | final price |
| GLD | five days earlier | -0.45% | final price |
| QQQ | that day | +1.12% | final price |
| QQQ | the next day | -1.76% | final price |
| QQQ | three days earlier | -1.03% | final price |
| QQQ | five days earlier | +1.64% | final price |
| SPY | that day | +0.53% | final price |
| SPY | the next day | -0.66% | final price |
| SPY | three days earlier | -0.75% | final price |
| SPY | five days earlier | +0.07% | final price |
| TLT | that day | +0.15% | final price |
| TLT | the next day | +2.01% | final price |
| TLT | three days earlier | -0.11% | final price |
| TLT | five days earlier | -1.55% | final price |
| VERX | that day | +2.44% | final price |
| VERX | the next day | +6.74% | final price |
| VERX | three days earlier | -6.63% | final price |
| VERX | five days earlier | -10.96% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | that day | +1.97% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | the next day | +4.03% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | three days earlier | -2.86% | final price |
| Vertex Pharmaceuticals Inc / Ma (VRTX) | five days earlier | -2.80% | final price |
Congressional trades in Vertex Pharmaceuticals Inc / Ma (VRTX) around 20 Oct 2026
- Rep. Rohit Khanna bought Vertex Pharmaceuticals Inc / Ma (VRTX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. David J. Taylor sold Vertex Pharmaceuticals Inc / Ma (VRTX), worth $1,001 - $15,000 on 26 Aug 2026. That is 55 days before publication. Filed 5 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Vertex Pharmaceuticals Inc / Ma (VRTX)
Companies tied to this story
- VRTX Vertex Pharmaceuticals Inc / Ma
For “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer),” Vertex Pharmaceuticals Inc / Ma (VRTX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> VRTX
How “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)” reaches Vertex Pharmaceuticals Inc / Ma (VRTX)
On 20 Oct 2026, “8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)” is the story that connects Vertex Pharmaceuticals Inc / Ma (VRTX) to this story.
The link for Vertex Pharmaceuticals Inc / Ma (VRTX) is this: SEC 8-K filing -> direct issuer disclosure -> VRTX
Dates in the story, and the Vertex Pharmaceuticals Inc / Ma (VRTX) price range
VRTX traded between 484.86 and 529.82 across 20 sessions. The latest close on file is 524.54.
How strong the case is around Vertex Pharmaceuticals Inc / Ma (VRTX)
44 out of 100
“8-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)” scores 44 out of 100. The score uses 1 sources, a +4.69% difference versus the S&P 500 (SPY), and 1 linked companies.